IL6 and depressive symptom measurement: Anxiety and depression are frequent comorbidities in the setting of PsA2 and have been linked with worse clinical outcomes and lower probability of achieving disease remission.93 Although they can be owed to devastating clinical symptomatology, pain and reduced quality of life, they are mechanistically linked with inflammatory processes and mediators like IL-6 and TNF.